N.V. GALEEVA

Kazan State Medical University, 49 Butlerov Str., Kazan, Russian Federation, 420012

Galeeva N.V. ― PhD (medicine), Assistant of the Infectiuos diseases Department, e-mail: Nelli_04@mail.ru, ORCID ID: 0000-0001-5080-6529

The effect of ozonotherapy on the number and functional activity of the blood platelets was studied in 70 patients with CHC. Conditionally, patients were divided into 3 groups according to the number of Tr, characteristic of the hemostasis phases: group 1 ― hypercoagulation, group 2 ― transitional phase between hyper- and hypocoagulation and group 3 ― hypocoagulation. It was revealed that before ozonotherapy for all phases of the ICE syndrome, there was an increase in aggregation of Tr platelets with an increase in their maximum amplitude and a decrease in the number of Tr in the phases of multidirectional shifts and hypocoagulation. Intravenous ozone therapy irrespective of the number of Tr contributed to a decrease in the maximum aggregation amplitude and an increase in the number of Tr with confidence in hypocoagulation.

Key words: platelet aggregation, ozonotherapy, chronic hepatitis C.

(For citation: Galeeva N.V. Influence of ozone therapy on parameters of platelet hemostasis in patients with chronic hepatitis C. Practical Medicine. 2018)

REFERENCES

1. Morozov Yu.A., Mednikov R.V., Charnaya M.A. Disorders of hemostasis in liver pathology and their diagnosis. Gemorragicheskie diatezy, trombozy, trombofilii, 2014, no. 1, pp. 162-174 (in Russ.).
2. Yagoda A.V., Koroy P.V. Patologiya pecheni i funktsiya trombotsitov (kliniko-patogeneticheskiy analiz) [Pathology of the liver and platelet function (clinical and pathogenetic analysis)]. Stavropol: StGMA, 2008. 273 p.
3. Senzolo M., Burra P., Cholongitas E., Burroughs A.K. New insights into the coagulopathy of liver disease and liver transplantation. World J. Gastroenterol, 2006, vol. 12, no. 48, pp. 7725-7736.
4. Sorinson S.N., Kozulin V.E. The clinical significance of the study of platelet hemostasis in viral hepatitis. Kazanskiy meditsinskiy zhurnal, 1983, vol. 64, no. 4, pp. 251-254 (in Russ.).
5. Krutov I.V., Davydkin I.L., Khayretdinov R.K et al. Disruption of hemostasis in patients with chronic hepatitis and cirrhosis of the liver of viral etiology (HCV) complicated by thrombocytopenia. Vestnik RUDN, seriya Meditsina, 2010, no. 3, pp. 139-141 (in Russ.).
6. Chekman I.S., Syrovaya O.A., Makarov V.A. et al. Ozon i ozonirovanie [Ozone and ozonation]. Kharkov: Tsifrovadrukarnya no. 1, 2013. 144 p.
7. Boyarinov A.G., Gordetsov A.S., Zhivulin N.E. et al. Solubility and decomposition of ozone in physiological solution. Nizhegorodskiy meditsinskiy zhurnal, 2000, no. 2, pp. 40-44 (in Russ.).
8. Maslennikov O.V., Kontorshchikova K.N., Shakhov B.E. Rukovodstvo po ozonoterapii [Guide to ozone therapy]. Nizhniy Novgorod: Istok, 2015. 346 p.
9. Stenton Glants. Mediko-biologicheskaya statistika [Biomedical statistics]. Praktika, 1999. 462 p.
10. Maleev V.V., Polyakova A.M., Kravchenko A.V. Narusheniya gemostaza pri infektsionnykh zabolevaniyakh [Violations of hemostasis in infectious diseases]. Moscow: De-Novo, 2005. 160 p.
11. Kozlovskiy V.I., Kovtun O.S., Seroukhova O.P. et al. Research methods and clinical significance of platelet aggregation. Focus on spontaneous aggregation. Vestnik VGMU, 2013, no. 3, pp. 79-91 (in Russ.).
12. Gazin I.K. Evaluation of some indicators of hemostasis in patients with complicated diabetes mellitus when using ozone therapy. Ehfferentnaya terapiya, 2001, vol. 7, no. 2, pp. 67-68 (in Russ.).
13. Fazylov V.Kh., Galeeva N.V., Zagidullina A.I. et al. Ozone therapy in the clinic of infectious diseases. Prakticheskaya meditsina, 2013, no. 5 (74), pp. 48-51 (in Russ.).
14. Galeeva N.V., Fazylov V.Kh., Valeeva I.Kh. Clinical and biochemical study of ozone therapy for chronic viral hepatitis B and C . Kazanskiy meditsinskiy zhurnal, 2014, vol. 95, no. 5, pp. 751-756 (in Russ.).